Dr Goel is a Clinician-Scientist at the University of Melbourne and Peter MacCallum Cancer Centre. Having spent ten years in Boston, where he completed his doctoral and postdoctoral research, Dr Goel returned to Australia in 2019. In addition to maintaining a clinical practice as an oncologist, he also leads a research group positions itself at the intersection of cell cycle biology, epigenetics, and tumour immunology in breast cancer. They have developed several new transgenic mouse models of breast cancer, which have proven valuable for uncovering new mechanisms of drug activity and resistance, and their work has been published in high-impact journals including Nature, Cancer Cell and Nature Cancer.

He serves as either Global PI or Translational PI for four randomised clinical trials in breast cancer and was appointed Chair of the American Society of Clinical Oncology Education Committee (2023). Dr Goel is also a recent awardee of a prestigious Snow Fellowship which will accelerate his laboratory’s work from 2022 – 2030.